Wednesday, January 28, 2009

Mergers and Acquisitions Likely to Continue in Pharm

Pin It Now!
According to Barrons, most major pharmaceutical CEOs agree that merger and acquisition activity is going to continue, and with significant pressure on the drug industry from generic competition, insufficient innovation, a tough Food and Drug Administration, and reimbursement limitations imposed by government and private payers, they believe that 12 major drug companies is unsustainable. What M&A's do you see coming in 2009. Do you agree with Barron's theories? Share with us.
Post a Comment